“…SNPs are also thought to be key enablers in realizing the concept of personalized medicine. For this reason, over the past several years a great deal of effort has been devoted to developing accurate, rapid, and cost-effective technologies for SNP analysis from restriction endonuclease mapping approach (Wilson et al, 1982), denaturing gradient gel electrophoresis (Borresen-Dale et al, 2001;Myers et al, 1985), RNase or chemical cleavage of mismatched heteroduplexes (Cotton and Grompe, 2001;Cotton et al, 1988;Theophilus et al, 1989) to newly developed techniques such as allele-specific PCR (Cook et al, 2012;Duan et al, 2009;Liu et al, 2012;Muneta et al, 2012;Myakishev et al, 2001), strand displacement amplification (SDA) (Shi et al, 2011;Van Ness et al, 2003;Wang et al, 2011Wang et al, , 2012aWang et al, , 2012b, rolling circle amplification (RCA) (Bi et al, 2010;Li et al, 2010;Wang et al, 2011Wang et al, , 2012aWang et al, , 2012bWu et al, 2010;Zhang et al, 2009), and technologies based upon chips (Tanaka et al, 2012;Van Bers et al, 2012) and microfluidic devices (Hatakeyama et al, 2009;Ng et al, 2007;Russom et al, 2003). However most of those techniques incorporate primer extensions or PCR assays to obtain adequate amounts of starting material.…”